Procter & Gamble Stock Forecast for 2022 - 2025 - 2030

Updated on 09/27/2022

Stock Rating
12
Price Target
$155.50
Consensus
Outperform
Upside
14.58%
Analysts
12
Stock Rating
12
Upside
14.58%
Analysts
12
Price Target
$155.50

Procter & Gamble Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Procter & Gamble were recently set by twelve distinguished experts, with an average mark of $155.50. If it reached this goal, it would represent a potential upside of approximately 14.58% from the previous closing price in September, 2022. The high end is $180.00, and the low is $125.00. If you are interested in PG stock, you should also look at its competitors.

$155.50

14.58% Upside

Outperform
Outperform

Procter & Gamble Fair Value Forecast for 2022 - 2025 - 2030

Procter & Gamble's Price has grown In the last four years, rising from $98.83 to $136.07 – a growth of 37.68%. In the next year, analysts believe that Fair Value will reach $146.61 – an increase of 7.75%. For the next eight years, experts predict that Procter & Gamble's Fair Value will grow at a rate of 61.27%.

2023 Fair Value Forecast
$146.61
2024 Fair Value Forecast
$159.49
2025 Fair Value Forecast
$173.31
2026 Fair Value Forecast
$194.62
2027 Fair Value Forecast
$183.61
2028 Fair Value Forecast
$195.32
2029 Fair Value Forecast
$206.33
2030 Fair Value Forecast
$219.45
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 12
$165.70 Buy/Sell $185.07 9.84%
ABBV Stock Forecast AbbVie Outperform 9
$141.21 Buy/Sell $164.23 10.47%
COST Stock Forecast Costco Wholesale Outperform 13
$480.30 Buy/Sell $565.43 17.11%
ABT Stock Forecast Abbott Laboratories Outperform 14
$99.84 Buy/Sell $128.88 26.20%
MO Stock Forecast Altria Group Hold 9
$41.47 Buy/Sell $50.03 20.57%

Procter & Gamble Revenue Forecast for 2022 - 2025 - 2030

Procter & Gamble's Revenue has grown In the last four years, rising from $66.83B to $80.19B – a growth of 19.98%. In the next year, analysts believe that Revenue will reach $82.95B – an increase of 3.45%. For the next eight years, experts predict that Procter & Gamble's Revenue will grow at a rate of 33.10%.

2023 Rev Forecast
$82.95B
2024 Rev Forecast
$86.53B
2025 Rev Forecast
$90.10B
2026 Rev Forecast
$95.82B
2027 Rev Forecast
$95.49B
2028 Rev Forecast
$99.14B
2029 Rev Forecast
$102.80B
2030 Rev Forecast
$106.73B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CL Stock Forecast Colgate-Palmolive Outperform 18
$75.00 Buy/Sell $82.26 9.33%
GSK Stock Forecast GSK Outperform 16
£13.25 Buy/Sell £16.08 43.02%
KER Stock Forecast Kering Outperform 18
473.05€ Buy/Sell 796.00€ 41.63%

Procter & Gamble Dividend per Share Forecast for 2022 - 2025 - 2030

Procter & Gamble's Dividend per Share has seen impressive growth In the last four years, rising from $2.79 to $3.52 – a growth of 26.16%. In the next year, analysts believe that Dividend per Share will reach $3.71 – an increase of 5.40%. For the next eight years, the forecast is for Dividend per Share to grow by 67.61%.

2023 DPS Forecast
$3.71
2024 DPS Forecast
$3.88
2025 DPS Forecast
$4.14
2026 DPS Forecast
$4.64
2027 DPS Forecast
$4.75
2028 DPS Forecast
$5.10
2029 DPS Forecast
$5.49
2030 DPS Forecast
$5.90
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
GIS Stock Forecast General Mills Hold 16
$78.66 Buy/Sell $76.67 -2.11%
BAYN Stock Forecast Bayer Outperform 7
48.37€ Buy/Sell 67.79€ 64.36%
ECL Stock Forecast Ecolab Outperform 18
$146.34 Buy/Sell $182.22 23.00%

Procter & Gamble Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last four years, Procter & Gamble's Free Cash Flow has grown, moving from $11.15B to $13.57B – an increase of 21.68%. In the next year, analysts predict that Free Cash Flow will jump to $15.74B – up 16.00% from the current level. Looking ahead to eight years, experts forecast that Free Cash Flow will grow by 57.91%.

2023 FCF Forecast
$15.74B
2024 FCF Forecast
$16.89B
2025 FCF Forecast
$17.82B
2026 FCF Forecast
$18.94B
2027 FCF Forecast
$18.94B
2028 FCF Forecast
$19.79B
2029 FCF Forecast
$20.51B
2030 FCF Forecast
$21.42B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
KMB Stock Forecast Kimberly-Clark Hold 16
$118.78 Buy/Sell $131.81 9.45%
BN Stock Forecast Danone Hold 18
48.61€ Buy/Sell 62.59€ 19.32%
ALC Stock Forecast Alcon Outperform 15
CHF57.42 Buy/Sell CHF0.00 47.44%

Procter & Gamble Net Income Forecast for 2022 - 2025 - 2030

In the last four years, Procter & Gamble's Net Income has grown by 51.20%, rising from $9.75B to $14.74B. For the next year, analysts predict that Net Income will reach $15.66B – an increase of 6.23%. Over the next eight years, experts believe that Procter & Gamble's Net Income will grow at a rate of 41.26%.

2023 NI Forecast
$15.66B
2024 NI Forecast
$16.73B
2025 NI Forecast
$17.56B
2026 NI Forecast
$19.07B
2027 NI Forecast
$18.37B
2028 NI Forecast
$19.20B
2029 NI Forecast
$19.92B
2030 NI Forecast
$20.82B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
K Stock Forecast Kellogg Hold 13
$72.93 Buy/Sell $74.16 2.84%
HEN3 Stock Forecast Henkel AG & Co. KGaA Hold 16
60.60€ Buy/Sell 95.86€ 10.56%
COLO B Stock Forecast Coloplast A/S Hold 18
kr760.00 Buy/Sell kr1.05k 35.53%

Procter & Gamble EBITDA Forecast for 2022 - 2025 - 2030

In the last four years, Procter & Gamble's EBITDA has seen an increase, rising from $16.20B to $20.62B. This represents a growth of 27.31%. Analysts predict that Procter & Gamble's EBITDA will increase in the upcoming year, reaching $22.25B. This would represent an increase of 7.92%. Over the next eight years, experts predict that Procter & Gamble's EBITDA will grow at a rate of 45.45%.

2023 EBITDA Forecast
$22.25B
2024 EBITDA Forecast
$23.74B
2025 EBITDA Forecast
$25.53B
2026 EBITDA Forecast
$27.03B
2027 EBITDA Forecast
$26.55B
2028 EBITDA Forecast
$27.71B
2029 EBITDA Forecast
$28.73B
2030 EBITDA Forecast
$29.99B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4452 Stock Forecast Kao Outperform 18
¥5.87k Buy/Sell ¥0.00 2.28%
CHD Stock Forecast Church & Dwight Hold 11
$75.26 Buy/Sell $90.41 18.39%
CPB Stock Forecast Campbell Soup Hold 16
$47.98 Buy/Sell $48.00 0.04%

Procter & Gamble EBIT Forecast for 2022 - 2025 - 2030

Procter & Gamble's EBIT has seen growth In the last four years, going from $13.36B to $17.81B – a gain of 33.30% In the next year, analysts believe that EBIT will reach $19.19B – an increase of 7.72%. For the next eight years, the forecast is forEBIT to grow by 47.53%.

2023 EBIT Forecast
$19.19B
2024 EBIT Forecast
$20.50B
2025 EBIT Forecast
$21.65B
2026 EBIT Forecast
$23.73B
2027 EBIT Forecast
$23.20B
2028 EBIT Forecast
$24.25B
2029 EBIT Forecast
$25.15B
2030 EBIT Forecast
$26.28B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PHIA Stock Forecast Koninklijke Philips N.V. Outperform 18
16.18€ Buy/Sell 50.07€ 88.50%
CA Stock Forecast Carrefour Outperform 18
14.63€ Buy/Sell 19.32€ 43.54%
BIM Stock Forecast bioMérieux Outperform 18
82.66€ Buy/Sell 113.60€ 30.66%

Procter & Gamble EPS Price Prediction Forecast for 2022 - 2025 - 2030

Procter & Gamble's EPS has grown In the last four years, rising from $4.22 to $5.81 – a growth of 37.68%. In the next year, analysts believe that EPS will reach $6.26 – an increase of 7.75%. For the next eight years, experts predict that Procter & Gamble's EPS will grow at a rate of 61.27%.

2023 EPS Forecast
$6.26
2024 EPS Forecast
$6.81
2025 EPS Forecast
$7.40
2026 EPS Forecast
$8.31
2027 EPS Forecast
$7.84
2028 EPS Forecast
$8.34
2029 EPS Forecast
$8.81
2030 EPS Forecast
$9.37
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
500124 Stock Forecast Dr. Reddy's Laboratories Outperform 18
Rp4.13k Buy/Sell Rp5.47k 19.78%
BBWI Stock Forecast Bath & Body Works Outperform 15
$34.75 Buy/Sell $52.00 38.13%
HYPE3 Stock Forecast Hypera Outperform 16
R$45.32 Buy/Sell R$44.01 -4.02%